New Jersey NJ
German biotech firm brings US headquarters to Route 1 corridor
ITM Isotope Technologies Munich is a leader in Targeted Radionuclide Therapy, an emerging class of cancer treatment.
ITM Isotope Technologies Munich is a leader in Targeted Radionuclide Therapy, an emerging class of cancer treatment.